UnitedHealth Competitors
| UNH Stock | USD 493.18 14.19 2.96% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of UnitedHealth Group competition on your existing holdings.
UnitedHealth |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of UnitedHealth Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
UnitedHealth Group Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between UnitedHealth Group and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of UnitedHealth and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of UnitedHealth Group does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between UnitedHealth Stock performing well and UnitedHealth Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze UnitedHealth Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CERT | 2.02 | (0.08) | (0.01) | 0.02 | 2.26 | 3.83 | 14.25 | |||
| HSTM | 1.00 | (0.23) | 0.00 | (0.22) | 0.00 | 1.56 | 4.67 | |||
| EVH | 1.49 | (0.14) | 0.00 | (0.04) | 0.00 | 2.38 | 19.46 | |||
| STRM | 5.29 | (0.08) | (0.01) | (0.01) | 5.16 | 16.28 | 44.75 | |||
| DH | 2.51 | (0.51) | 0.00 | (0.15) | 0.00 | 5.45 | 13.17 | |||
| SLP | 2.24 | 0.20 | 0.08 | 0.20 | 2.55 | 5.10 | 29.29 | |||
| AGTI | 1.90 | 0.58 | 0.27 | 0.60 | 1.39 | 3.89 | 29.56 |
Cross Equities Net Income Analysis
Compare UnitedHealth Group and related stocks such as Certara, HealthStream, and Evolent Health Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CERT | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (33.3 M) | (8.9 M) | (49.4 M) | (13.3 M) | 14.7 M | (55.4 M) | (52.6 M) |
| HSTM | (4.5 M) | 6.9 M | 7.6 M | 8.4 M | 10.4 M | 8.6 M | 3.8 M | 10 M | 32.2 M | 15.8 M | 14.1 M | 5.8 M | 12.1 M | 15.2 M | 16 M |
| EVH | 20 M | 20 M | 20 M | 20 M | (25.2 M) | 332.5 M | (159.7 M) | (60.7 M) | (52.7 M) | (305.6 M) | (334.2 M) | (30.3 M) | (18.7 M) | (113 M) | (107.4 M) |
| STRM | (300 K) | 12.6 K | (5.4 M) | (11.7 M) | (12 M) | (4.3 M) | (5.2 M) | (3.1 M) | (5.9 M) | (2.9 M) | (4.8 M) | (6.9 M) | (11.4 M) | (10.2 M) | (9.7 M) |
| DH | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (36.4 M) | (87.6 M) | (61.3 M) | (22.3 M) | (202.4 M) | (192.3 M) |
| SLP | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 5.8 M | 8.9 M | 8.6 M | 9.3 M | 9.8 M | 12.5 M | 10 M | 11.5 M | 12 M |
| AGTI | (31.9 M) | (31.9 M) | (31.9 M) | (31.9 M) | (31.9 M) | (31.9 M) | (31.9 M) | (31.9 M) | (31.9 M) | (31.2 M) | (22.2 M) | 24 M | 30.2 M | (19.4 M) | (18.5 M) |
UnitedHealth Group and related stocks such as Certara, HealthStream, and Evolent Health Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in UnitedHealth Group financial statement analysis. It represents the amount of money remaining after all of UnitedHealth Group Incorporated operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.UnitedHealth Group Competitive Analysis
The better you understand UnitedHealth Group competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, UnitedHealth Group's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across UnitedHealth Group's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
UnitedHealth Group Competition Performance Charts
Five steps to successful analysis of UnitedHealth Group Competition
UnitedHealth Group's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by UnitedHealth Group in relation to its competition. UnitedHealth Group's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of UnitedHealth Group in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact UnitedHealth Group's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to UnitedHealth Group, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your UnitedHealth Group position
In addition to having UnitedHealth Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out UnitedHealth Group Correlation with its peers. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.16 | Dividend Share 7.52 | Earnings Share 23.87 | Revenue Per Share 411.257 | Quarterly Revenue Growth 0.086 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.